Silica Nanoparticles Induce Ferroptosis, Reprogram Immunity in Prostate Cancer Models

Ultrasmall fluorescent core‑shell silica nanoparticles—best known for their roles in medical imaging applications —are now showing surprising therapeutic muscle. Originally engineered as inert carriers for imaging agents, these particles, called Cornell Prime dots (C’ dots), have steadily expanded their résumé. In a new preclinical study, researchers at Weill Cornell Medicine report that these engineered silica nanoparticles can directly kill prostate tumor cells while reawakening antitumor immunity , offering a potential new edge in a disease where immunotherapy has historically struggled.